Exposure to Polyhexamethylene Guanidine Exacerbates Bronchial Hyperresponsiveness and Lung Inflammation in a Mouse Model of Ovalbumin-Induced Asthma
Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in c...
Saved in:
Published in | Allergy, asthma & immunology research Vol. 13; no. 4; pp. 655 - 664 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Seoul
Korean Academy of Asthma, Allergy and Clinical Immunology
01.07.2021
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 대한천식알레르기학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2092-7355 2092-7363 |
DOI | 10.4168/aair.2021.13.4.655 |
Cover
Loading…
Abstract | Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma. |
---|---|
AbstractList | Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma.Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma. Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma. KCI Citation Count: 0 Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma. Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been confirmed to cause severe lung inflammation and fibrosis in mice. Recent evidence also indicates that HDs exposure increases the asthma risk in children, but the underlying mechanisms remain unclear. We aimed to investigate the effects of PHMG exposure on asthma in mice and the potential underlying mechanisms. BALB/c mice were intranasally administered PHMG (0.1 mg/kg/day; 5 days per week) during 2 episodes of ovalbumin (OVA) sensitization and were then challenged with 1% OVA by inhalation. Bronchial hyperresponsiveness (BHR), inflammatory cell influx into bronchoalveolar lavage (BAL) fluid, serum total and OVA-specific immunoglobulin (Ig) E levels, and histopathological changes in the lung were analyzed. The levels of asthma-related cytokines and chemokines were assayed in the lung tissues to evaluate possible mechanisms. Exposure to PHMG following OVA sensitization and challenge significantly enhanced BHR, inflammatory cell counts in BAL fluid, airway inflammation, and total serum IgE levels in the asthma mouse model. In addition, the levels of chemokine ligand (CCL) 11 and serpine F1/pigment epithelium-derived factor (SERPINF1) were significantly elevated in the lungs of these mice compared to those in the control and OVA-treated only groups. Our findings suggest that PHMG can enhance the development of allergic responses and lung inflammation via CCL11- and SERPINF1-induced signaling in a mouse model of asthma. |
Author | Park, Min Jee Lee, So-Yeon Lee, Seung-Hwa Cho, Hyun-Ju Yang, Song-I Go, Han-Na Song, Kun Baek Yoon, Jisun Jung, Sungsu Lee, Eun Ahn, Jae-Rin Hong, Soo-Jong |
AuthorAffiliation | 5 Department of Pediatrics, International St. Mary's hospital, Catholic Kwandong University, Incheon, Korea 2 Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 7 Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea 4 Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea 3 Department of Pediatrics, Mediplex Sejong Hospital, Incheon, Korea 6 Department of Pediatrics, Chonnam National University College of Medicine, Gwangju, Korea 1 Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: 6 Department of Pediatrics, Chonnam National University College of Medicine, Gwangju, Korea – name: 4 Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea – name: 1 Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea – name: 7 Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea – name: 3 Department of Pediatrics, Mediplex Sejong Hospital, Incheon, Korea – name: 2 Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – name: 5 Department of Pediatrics, International St. Mary's hospital, Catholic Kwandong University, Incheon, Korea |
Author_xml | – sequence: 1 givenname: Seung-Hwa orcidid: 0000-0001-9359-0318 surname: Lee fullname: Lee, Seung-Hwa organization: Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea – sequence: 2 givenname: Jae-Rin orcidid: 0000-0002-7653-3052 surname: Ahn fullname: Ahn, Jae-Rin organization: Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea – sequence: 3 givenname: Han-Na orcidid: 0000-0003-0730-5133 surname: Go fullname: Go, Han-Na organization: Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea – sequence: 4 givenname: So-Yeon orcidid: 0000-0002-2499-0702 surname: Lee fullname: Lee, So-Yeon organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 5 givenname: Min Jee orcidid: 0000-0003-0891-1311 surname: Park fullname: Park, Min Jee organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 6 givenname: Kun Baek orcidid: 0000-0001-6981-6292 surname: Song fullname: Song, Kun Baek organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 7 givenname: Jisun orcidid: 0000-0002-4904-9118 surname: Yoon fullname: Yoon, Jisun organization: Department of Pediatrics, Mediplex Sejong Hospital, Incheon, Korea – sequence: 8 givenname: Sungsu orcidid: 0000-0002-0559-4982 surname: Jung fullname: Jung, Sungsu organization: Department of Pediatrics, Pusan National University Yangsan Hospital, Yangsan, Korea – sequence: 9 givenname: Hyun-Ju orcidid: 0000-0003-4282-4000 surname: Cho fullname: Cho, Hyun-Ju organization: Department of Pediatrics, International St. Mary's hospital, Catholic Kwandong University, Incheon, Korea – sequence: 10 givenname: Eun orcidid: 0000-0002-7462-0144 surname: Lee fullname: Lee, Eun organization: Department of Pediatrics, Chonnam National University College of Medicine, Gwangju, Korea – sequence: 11 givenname: Song-I orcidid: 0000-0002-9648-4585 surname: Yang fullname: Yang, Song-I organization: Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea – sequence: 12 givenname: Soo-Jong orcidid: 0000-0003-1409-2113 surname: Hong fullname: Hong, Soo-Jong organization: Department of Pediatrics, Childhood Asthma Atopy Center, Humidifier Disinfectant Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002737529$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9UstqGzEUHUpK82h-oCtBN-3C7ug1M9oU3OAmBpeUkq6FRroTK9FIrjRj7P_oB0e2Q6BZVAvdi3TO4XLuOS9OfPBQFB9wOWW4ar4oZeOUlARPMZ2yacX5m-KMlIJMalrRk5ee89PiMqWHMh-KGavYu-KUMoIJ5_is-DvfrkMaI6AhoJ_B7VawVT0Mq50DD-h6VN4am7v5VmmIrRogoW8xeL2yyqGb3RpihLQOPtlNZqSElDdoOfp7tPCdU32vBhs8sh4p9COMCfJtwKHQoduNcu3YWz9ZeDNqMGiWhlWv3hdvO-USXD7Xi-L39_nd1c1keXu9uJotJ5oxPEwoq4RQumpxrbmptWjBdKAV5mVXAnBjmo5WrAHBBanzozaCNGVb67ZjTd3Si-LzUdfHTj5qK4Oyh3of5GOUs193CykaRkvGMvbrEbse2x6MBj9E5eQ62l7F3YH574-3q6yzkU02OvudBT49C8TwZ4Q0yN4mDc4pD9kWSThrqGCC4wz9-Ar6EMbosxV7lKhJXuseRY4oHUNKEbqXYXAp9xmR-4zIfUYkppLJnJFMal6RtB0OG8pDW_c_6hPEecay |
CitedBy_id | crossref_primary_10_3389_fphar_2023_1114739 crossref_primary_10_3346_jkms_2022_37_e257 crossref_primary_10_1016_j_envpol_2024_124728 crossref_primary_10_3346_jkms_2022_37_e319 |
Cites_doi | 10.1172/JCI10259 10.1016/j.fct.2014.04.027 10.1016/j.jaci.2004.11.017 10.1016/S0002-9440(10)61235-7 10.1289/ehp.10846 10.1007/s11882-017-0681-6 10.1126/science.282.5397.2261 10.1074/jbc.M208339200 10.1186/1465-9921-6-106 10.1111/j.1365-2222.2006.02586.x 10.1177/039463200802100105 10.1164/rccm.201805-0840LE 10.1378/chest.09-1895 10.1038/s41598-017-05654-w 10.1038/mi.2012.109 10.1056/NEJMoa1007302 10.1155/2010/318029 10.1084/jem.20080452 10.1007/s00204-006-0075-3 10.1007/s00204-015-1486-9 10.4168/aair.2020.12.1.86 10.1097/ACI.0b013e32830a7086 10.1177/039463200702000409 10.1038/icb.2009.101 10.4168/aair.2019.11.4.450 10.1172/JCI36130 10.1164/rccm.200308-1151OC 10.1111/j.0105-2896.2004.00210.x 10.1080/00039890109604447 10.1165/rcmb.2004-0273OC 10.1146/annurev.immunol.21.120601.141142 10.1111/j.1440-1843.2012.02195.x 10.1016/j.jaci.2005.08.057 10.1371/journal.pone.0151849 10.1378/chest.107.3.711 10.4168/aair.2020.12.6.934 10.1186/rr5 10.1016/j.cyto.2015.05.008 10.1097/ACI.0b013e3282f42696 10.4049/jimmunol.163.11.6321 10.1021/es300567j 10.1152/ajplung.00188.2013 10.1023/A:1015039328620 10.4168/aair.2012.4.3.150 10.1016/j.scitotenv.2017.10.237 |
ContentType | Journal Article |
Copyright | Copyright Korean Academy of Asthma, Allergy and Clinical Immunology Jul 2021 Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease. Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease |
Copyright_xml | – notice: Copyright Korean Academy of Asthma, Allergy and Clinical Immunology Jul 2021 – notice: Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease. – notice: Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease |
DBID | AAYXX CITATION 7T5 7U7 C1K H94 7X8 5PM ACYCR |
DOI | 10.4168/aair.2021.13.4.655 |
DatabaseName | CrossRef Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2092-7363 |
EndPage | 664 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9843044 PMC8255342 10_4168_aair_2021_13_4_655 |
GrantInformation_xml | – fundername: ; grantid: NIER-SP2020-007 |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAKDD AAYXX ACPRK ADBBV ADRAZ AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION C~G DIK DYU E3Z EF. F5P GX1 HYE KQ8 M48 O5R O5S OK1 PGMZT RPM 7T5 7U7 C1K H94 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c441t-34699ac6b17c5d7c9bedfeca150f0ee5dd8f3648e9592750fcd9280b7cbf487b3 |
IEDL.DBID | M48 |
ISSN | 2092-7355 |
IngestDate | Sun Mar 09 07:51:56 EDT 2025 Thu Aug 21 13:28:00 EDT 2025 Fri Jul 11 07:26:07 EDT 2025 Mon Jun 30 11:59:35 EDT 2025 Fri Jul 04 01:06:57 EDT 2025 Thu Apr 24 23:02:25 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-34699ac6b17c5d7c9bedfeca150f0ee5dd8f3648e9592750fcd9280b7cbf487b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6981-6292 0000-0002-7462-0144 0000-0002-9648-4585 0000-0002-0559-4982 0000-0003-4282-4000 0000-0002-2499-0702 0000-0001-9359-0318 0000-0003-0891-1311 0000-0002-7653-3052 0000-0003-1409-2113 0000-0003-0730-5133 0000-0002-4904-9118 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4168/aair.2021.13.4.655 |
PMID | 34212551 |
PQID | 2549727351 |
PQPubID | 2048270 |
PageCount | 10 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9843044 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8255342 proquest_miscellaneous_2548394951 proquest_journals_2549727351 crossref_primary_10_4168_aair_2021_13_4_655 crossref_citationtrail_10_4168_aair_2021_13_4_655 |
PublicationCentury | 2000 |
PublicationDate | 2021-07-01 |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Seoul |
PublicationPlace_xml | – name: Seoul |
PublicationTitle | Allergy, asthma & immunology research |
PublicationYear | 2021 |
Publisher | Korean Academy of Asthma, Allergy and Clinical Immunology The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 대한천식알레르기학회 |
Publisher_xml | – name: Korean Academy of Asthma, Allergy and Clinical Immunology – name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease – name: 대한천식알레르기학회 |
References | Kasahara (10.4168/aair.2021.13.4.655_ref38) 2000; 106 Wynn (10.4168/aair.2021.13.4.655_ref45) 2003; 21 Gowers (10.4168/aair.2021.13.4.655_ref18) 2012; 17 Grünig (10.4168/aair.2021.13.4.655_ref43) 1998; 282 Folli (10.4168/aair.2021.13.4.655_ref10) 2008; 8 Puxeddu (10.4168/aair.2021.13.4.655_ref32) 2006; 117 Yoon (10.4168/aair.2021.13.4.655_ref7) 2018; 198 Bao (10.4168/aair.2021.13.4.655_ref41) 2015; 75 Kindstedt (10.4168/aair.2021.13.4.655_ref30) 2017; 7 Suda (10.4168/aair.2021.13.4.655_ref3) 1995; 107 Donaldson (10.4168/aair.2021.13.4.655_ref17) 2000; 1 Murphy (10.4168/aair.2021.13.4.655_ref8) 2010; 137 Koike (10.4168/aair.2021.13.4.655_ref21) 2008; 21 Ying (10.4168/aair.2021.13.4.655_ref27) 1999; 163 Spira (10.4168/aair.2021.13.4.655_ref39) 2004; 31 Mentink-Kane (10.4168/aair.2021.13.4.655_ref42) 2004; 202 Lee (10.4168/aair.2021.13.4.655_ref15) 2020; 12 Ege (10.4168/aair.2021.13.4.655_ref12) 2011; 364 Inoue (10.4168/aair.2021.13.4.655_ref20) 2006; 80 Kim (10.4168/aair.2021.13.4.655_ref6) 2016; 90 Shaw (10.4168/aair.2021.13.4.655_ref37) 2014; 6 Forbes (10.4168/aair.2021.13.4.655_ref44) 2010; 88 Bergeron (10.4168/aair.2021.13.4.655_ref9) 2010; 17 Jaakkola (10.4168/aair.2021.13.4.655_ref14) 2008; 116 Dorman (10.4168/aair.2021.13.4.655_ref28) 2005; 115 Lee (10.4168/aair.2021.13.4.655_ref4) 2012; 46 Bocchino (10.4168/aair.2021.13.4.655_ref29) 2002; 57 Park (10.4168/aair.2021.13.4.655_ref47) 2016; 11 Acevedo (10.4168/aair.2021.13.4.655_ref13) 2019; 11 Huaux (10.4168/aair.2021.13.4.655_ref34) 2005; 167 Junttila (10.4168/aair.2021.13.4.655_ref46) 2008; 205 Aleshina (10.4168/aair.2021.13.4.655_ref1) 2001; 33 Korea Centers for Disease Control and Prevention (10.4168/aair.2021.13.4.655_ref2) 2011; 4 Walters (10.4168/aair.2021.13.4.655_ref11) 2008; 8 Thompson (10.4168/aair.2021.13.4.655_ref25) 2001; 56 Shin (10.4168/aair.2021.13.4.655_ref35) 2014; 306 Jang (10.4168/aair.2021.13.4.655_ref24) 2012; 4 Draijer (10.4168/aair.2021.13.4.655_ref31) 2017; 17 Park (10.4168/aair.2021.13.4.655_ref48) 2018; 616-617 de Haar (10.4168/aair.2021.13.4.655_ref23) 2006; 36 Lin (10.4168/aair.2021.13.4.655_ref16) 2020; 12 Cosgrove (10.4168/aair.2021.13.4.655_ref36) 2004; 170 Song (10.4168/aair.2021.13.4.655_ref5) 2014; 69 Inoue (10.4168/aair.2021.13.4.655_ref19) 2005; 6 Isgrò (10.4168/aair.2021.13.4.655_ref33) 2013; 6 Barnes (10.4168/aair.2021.13.4.655_ref26) 2008; 118 Meyer (10.4168/aair.2021.13.4.655_ref40) 2002; 277 Inoue (10.4168/aair.2021.13.4.655_ref22) 2007; 20 |
References_xml | – volume: 106 start-page: 1311 year: 2000 ident: 10.4168/aair.2021.13.4.655_ref38 publication-title: J Clin Invest doi: 10.1172/JCI10259 – volume: 69 start-page: 267 year: 2014 ident: 10.4168/aair.2021.13.4.655_ref5 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2014.04.027 – volume: 4 start-page: 817 year: 2011 ident: 10.4168/aair.2021.13.4.655_ref2 publication-title: Public Health Wkly Rep – volume: 115 start-page: 501 year: 2005 ident: 10.4168/aair.2021.13.4.655_ref28 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2004.11.017 – volume: 167 start-page: 1485 year: 2005 ident: 10.4168/aair.2021.13.4.655_ref34 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)61235-7 – volume: 116 start-page: 845 year: 2008 ident: 10.4168/aair.2021.13.4.655_ref14 publication-title: Environ Health Perspect doi: 10.1289/ehp.10846 – volume: 17 start-page: 12 year: 2017 ident: 10.4168/aair.2021.13.4.655_ref31 publication-title: Curr Allergy Asthma Rep doi: 10.1007/s11882-017-0681-6 – volume: 282 start-page: 2261 year: 1998 ident: 10.4168/aair.2021.13.4.655_ref43 publication-title: Science doi: 10.1126/science.282.5397.2261 – volume: 277 start-page: 45400 year: 2002 ident: 10.4168/aair.2021.13.4.655_ref40 publication-title: J Biol Chem doi: 10.1074/jbc.M208339200 – volume: 6 start-page: 106 year: 2005 ident: 10.4168/aair.2021.13.4.655_ref19 publication-title: Respir Res doi: 10.1186/1465-9921-6-106 – volume: 36 start-page: 1469 year: 2006 ident: 10.4168/aair.2021.13.4.655_ref23 publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2006.02586.x – volume: 21 start-page: 35 year: 2008 ident: 10.4168/aair.2021.13.4.655_ref21 publication-title: Int J Immunopathol Pharmacol doi: 10.1177/039463200802100105 – volume: 198 start-page: 1583 year: 2018 ident: 10.4168/aair.2021.13.4.655_ref7 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201805-0840LE – volume: 137 start-page: 1417 year: 2010 ident: 10.4168/aair.2021.13.4.655_ref8 publication-title: Chest doi: 10.1378/chest.09-1895 – volume: 7 start-page: 5334 year: 2017 ident: 10.4168/aair.2021.13.4.655_ref30 publication-title: Sci Rep doi: 10.1038/s41598-017-05654-w – volume: 6 start-page: 718 year: 2013 ident: 10.4168/aair.2021.13.4.655_ref33 publication-title: Mucosal Immunol doi: 10.1038/mi.2012.109 – volume: 364 start-page: 701 year: 2011 ident: 10.4168/aair.2021.13.4.655_ref12 publication-title: N Engl J Med doi: 10.1056/NEJMoa1007302 – volume: 17 start-page: e85 year: 2010 ident: 10.4168/aair.2021.13.4.655_ref9 publication-title: Can Respir J doi: 10.1155/2010/318029 – volume: 205 start-page: 2595 year: 2008 ident: 10.4168/aair.2021.13.4.655_ref46 publication-title: J Exp Med doi: 10.1084/jem.20080452 – volume: 80 start-page: 614 year: 2006 ident: 10.4168/aair.2021.13.4.655_ref20 publication-title: Arch Toxicol doi: 10.1007/s00204-006-0075-3 – volume: 90 start-page: 617 year: 2016 ident: 10.4168/aair.2021.13.4.655_ref6 publication-title: Arch Toxicol doi: 10.1007/s00204-015-1486-9 – volume: 12 start-page: 86 year: 2020 ident: 10.4168/aair.2021.13.4.655_ref15 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2020.12.1.86 – volume: 8 start-page: 367 year: 2008 ident: 10.4168/aair.2021.13.4.655_ref10 publication-title: Curr Opin Allergy Clin Immunol doi: 10.1097/ACI.0b013e32830a7086 – volume: 20 start-page: 737 year: 2007 ident: 10.4168/aair.2021.13.4.655_ref22 publication-title: Int J Immunopathol Pharmacol doi: 10.1177/039463200702000409 – volume: 88 start-page: 240 year: 2010 ident: 10.4168/aair.2021.13.4.655_ref44 publication-title: Immunol Cell Biol doi: 10.1038/icb.2009.101 – volume: 11 start-page: 450 year: 2019 ident: 10.4168/aair.2021.13.4.655_ref13 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2019.11.4.450 – volume: 118 start-page: 3546 year: 2008 ident: 10.4168/aair.2021.13.4.655_ref26 publication-title: J Clin Invest doi: 10.1172/JCI36130 – volume: 6 start-page: 1532 year: 2014 ident: 10.4168/aair.2021.13.4.655_ref37 publication-title: J Thorac Dis – volume: 170 start-page: 242 year: 2004 ident: 10.4168/aair.2021.13.4.655_ref36 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200308-1151OC – volume: 202 start-page: 191 year: 2004 ident: 10.4168/aair.2021.13.4.655_ref42 publication-title: Immunol Rev doi: 10.1111/j.0105-2896.2004.00210.x – volume: 56 start-page: 234 year: 2001 ident: 10.4168/aair.2021.13.4.655_ref25 publication-title: Arch Environ Health doi: 10.1080/00039890109604447 – volume: 31 start-page: 601 year: 2004 ident: 10.4168/aair.2021.13.4.655_ref39 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2004-0273OC – volume: 21 start-page: 425 year: 2003 ident: 10.4168/aair.2021.13.4.655_ref45 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.120601.141142 – volume: 57 start-page: 17 year: 2002 ident: 10.4168/aair.2021.13.4.655_ref29 publication-title: Allergy – volume: 17 start-page: 887 year: 2012 ident: 10.4168/aair.2021.13.4.655_ref18 publication-title: Respirology doi: 10.1111/j.1440-1843.2012.02195.x – volume: 117 start-page: 103 year: 2006 ident: 10.4168/aair.2021.13.4.655_ref32 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2005.08.057 – volume: 11 start-page: e0151849 year: 2016 ident: 10.4168/aair.2021.13.4.655_ref47 publication-title: PLoS One doi: 10.1371/journal.pone.0151849 – volume: 107 start-page: 711 year: 1995 ident: 10.4168/aair.2021.13.4.655_ref3 publication-title: Chest doi: 10.1378/chest.107.3.711 – volume: 12 start-page: 934 year: 2020 ident: 10.4168/aair.2021.13.4.655_ref16 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2020.12.6.934 – volume: 1 start-page: 12 year: 2000 ident: 10.4168/aair.2021.13.4.655_ref17 publication-title: Respir Res doi: 10.1186/rr5 – volume: 75 start-page: 25 year: 2015 ident: 10.4168/aair.2021.13.4.655_ref41 publication-title: Cytokine doi: 10.1016/j.cyto.2015.05.008 – volume: 8 start-page: 39 year: 2008 ident: 10.4168/aair.2021.13.4.655_ref11 publication-title: Curr Opin Allergy Clin Immunol doi: 10.1097/ACI.0b013e3282f42696 – volume: 163 start-page: 6321 year: 1999 ident: 10.4168/aair.2021.13.4.655_ref27 publication-title: J Immunol doi: 10.4049/jimmunol.163.11.6321 – volume: 46 start-page: 2498 year: 2012 ident: 10.4168/aair.2021.13.4.655_ref4 publication-title: Environ Sci Technol doi: 10.1021/es300567j – volume: 306 start-page: L620 year: 2014 ident: 10.4168/aair.2021.13.4.655_ref35 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00188.2013 – volume: 33 start-page: 421 year: 2001 ident: 10.4168/aair.2021.13.4.655_ref1 publication-title: Fibre Chem doi: 10.1023/A:1015039328620 – volume: 4 start-page: 150 year: 2012 ident: 10.4168/aair.2021.13.4.655_ref24 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2012.4.3.150 – volume: 616-617 start-page: 855 year: 2018 ident: 10.4168/aair.2021.13.4.655_ref48 publication-title: Sci Total Environ doi: 10.1016/j.scitotenv.2017.10.237 |
SSID | ssj0000314464 |
Score | 2.2625995 |
Snippet | Humidifier disinfectants (HDs) exposure has now been associated with acute lung injury and pulmonary fibrosis; polyhexamethylene guanidine (PHMG) has been... |
SourceID | nrf pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 655 |
SubjectTerms | Asthma Brief Communication Bronchus Chemokines Cytokines Disinfectants Epithelium Exposure Fibrosis Guanidine Health risks Hypersensitivity Immunoglobulin E Inflammation Inhalation Lung diseases Lungs Ovalbumin Pigment epithelium-derived factor Respiration Respiratory tract diseases 내과학 |
Title | Exposure to Polyhexamethylene Guanidine Exacerbates Bronchial Hyperresponsiveness and Lung Inflammation in a Mouse Model of Ovalbumin-Induced Asthma |
URI | https://www.proquest.com/docview/2549727351 https://www.proquest.com/docview/2548394951 https://pubmed.ncbi.nlm.nih.gov/PMC8255342 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002737529 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Allergy, 2021, Asthma & Immunology Research, 13(4), , pp.655-664 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIlW9VDzFQqkM4oYS1nGcxwlVaKstYoEDK5WTZTt2N2pw2t0U7f4PfjAzSXZFJODAKYfYeXjGnu-LJ_MR8jpLGHPapEEB0SWII5MEWkdZoJhSIlFZXrRyb7NPyXQef7gUl3tkK3fUD-Dqj9QO9aTmyypc327ewYQH_BoCnMjeKlViZc-IhYyHcZgIsU_uQWRKkIzNerjfrswc2Q9uNEfjHIAlxNruP5q_XOaIHHLcMRWCDcLWvl-6ASId5lP-FqDO75PjHlnSs84VHpA96x-Sw1m_d_6I_Jysb2r8Hkibmn6pq83CrhUKSG8g8FgKvuJLCGSWTtbKwGAjCKXA0j1mQ1d0CoQVhTzajNpuhaTKF_QjrBb0wjvwrO4vSFp6quisvltZikprFa0d_fyjzYMufYBaIcYW9GzVLL6rx2R-Pvn6fhr0mgyBAeDUBBzodK5MollqRJGaXNvCWaMAV7qxtaIoMseTOLO5yLF0vDNFHmVjnRrtgBtp_oQc-Nrbp4S6GNCqdmmmIri2ijQHKGVTrlgOdF_EI8K2Qy5NX7AcdTMqCcQFLSbRYhItJhmXsQSLjcibXZ-brlzHP1u_AkvKa1NKrLKNx6taXi8lcIkLmWcxH8fwGCdbQ8ute0qk1Yj8BBuRl7vTMDNxu0V5C2OMbQB9AgGFNunAQXaPhncdnvHloq3xDcRdgO89---ez8kRvmuXWXxCDprlnX0B-KnRp8Acvs1P26nxC1XcHQo |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exposure+to+Polyhexamethylene+Guanidine+Exacerbates+Bronchial+Hyperresponsiveness+and+Lung+Inflammation+in+a+Mouse+Model+of+Ovalbumin-Induced+Asthma&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Lee%2C+Seung-Hwa&rft.au=Ahn%2C+Jae-Rin&rft.au=Go%2C+Han-Na&rft.au=Lee%2C+So-Yeon&rft.date=2021-07-01&rft.pub=The+Korean+Academy+of+Asthma%2C+Allergy+and+Clinical+Immunology%3B+The+Korean+Academy+of+Pediatric+Allergy+and+Respiratory+Disease&rft.issn=2092-7355&rft.eissn=2092-7363&rft.volume=13&rft.issue=4&rft.spage=655&rft.epage=664&rft_id=info:doi/10.4168%2Faair.2021.13.4.655&rft_id=info%3Apmid%2F34212551&rft.externalDocID=PMC8255342 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon |